Bayamban, Eto H.

HRN: 22-57-27  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/04/2025
05/10/2025
IV
2.25g
Q6
CAP-MR
Rejected 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Non-compliant To Guidelines